You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 108 No. 5, May 1990 TABLE OF CONTENTS
  Archives
  •  Online Features
  CLINICAL SCIENCES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

A Randomized Placebo-Controlled Trial of Cysteamine Eye Drops in Nephropathic Cystinosis

Muriel I. Kaiser-Kupfer, MD; Maria A. Gazzo, MD; Manuel B. Datiles, MD; Rafael C. Caruso, MD; Ernest M. Kuehl; William A. Gahl, MD, PhD

Arch Ophthalmol. 1990;108(5):689-693.


Abstract

• Eighteen patients with nephropathic cystinosis who were younger than 42 months and 11 patients 4 to 31 years of age were entered into a double-masked, randomized, placebo-controlled trial of topical cysteamine eye drops between November 1985 and September 1989. Eight of the younger patients and 2 of the older patients showed marked clearing of corneal crystals in one eye compared with the fellow eye. When the code was broken, all 10 patients were found to have received cysteamine eye drops in the improved eye. Of the remaining 19 patients 4 were unavailable for follow-up. In 15 patients no marked difference was noted between the two eyes. Eight have presumably been in the protocol for too short a time and several have been poor compliers with the therapy. These results not only demonstrate the potential for primary prevention of corneal crystal deposition but also, for the first time, offer the possibility of reversing the corneal complications of cystinosis in older patients.



Author Affiliations

From the Ophthalmic Genetics and Clinical Services Branch, National Eye Institute (Drs Kaiser-Kupfer, Gazzo, Datiles, and Caruso and Mr Kuehl), and the Section on Human Biochemical Genetics, Human Genetics Branch, National Institute of Child Health and Human Development (Dr Gahl), the National Institutes of Health, Bethesda, Md.


Footnotes

Accepted for publication January 13, 1990.

Reprint requests to NIH-NEI, 9000 Rockville Pike, Bldg 10, Room 10N226, Bethesda, MD 20892 (Dr Kaiser-Kupfer).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Nephropathic Cystinosis in Adults: Natural History and Effects of Oral Cysteamine Therapy
Gahl et al.
ANN INTERN MED 2007;147:242-250.
ABSTRACT | FULL TEXT  

A multicentre randomised double masked clinical trial of a new formulation of topical cysteamine for the treatment of corneal cystine crystals in cystinosis
Tsilou et al.
Br J Ophthalmol 2003;87:28-31.
ABSTRACT | FULL TEXT  

Cystinosis: Antibodies and Healthy Bodies
Kleta and Gahl
J. Am. Soc. Nephrol. 2002;13:2189-2191.
FULL TEXT  

Cystinosis
Gahl et al.
NEJM 2002;347:111-121.
FULL TEXT  

Pulmonary Dysfunction in Adults With Nephropathic Cystinosis
Anikster et al.
Chest 2001;119:394-401.
ABSTRACT | FULL TEXT  

Ultrasound Biomicroscopy of the Eye in Cystinosis
Mungan et al.
Arch Ophthalmol 2000;118:1329-1333.
ABSTRACT | FULL TEXT  

Classic Nephropathic Cystinosis as an Adult Disease
Theodoropoulos et al.
JAMA 1993;270:2200-2204.
ABSTRACT  

Improved Renal Function in Children with Cystinosis Treated with Cysteamine
Markello et al.
NEJM 1993;328:1157-1162.
ABSTRACT | FULL TEXT  

Ocular Manifestations of Nephropathic Cystinosis: The French-Canadian Experience in a Genetically Homogeneous Population
Richler et al.
Arch Ophthalmol 1991;109:359-362.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1990 American Medical Association. All Rights Reserved.